Drug Profile
Research programme: 17-beta hydroxysteroid dehydrogenase type 2 inhibitors - ElexoPharma
Alternative Names: 17β-HSD2 inhibitors - ElexoPharmaLatest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator ElexoPharm GmbH
- Class
- Mechanism of Action 17-hydroxysteroid dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Osteoporosis in Germany (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Osteoporosis in Germany
- 17 Jul 2016 Preclinical trials in Osteoporosis in Germany (unspecified route)